3137 results for «2157»
3137 results
Challenging scenarios: bioprosthetic valve dysfunction
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the different causes of bioprosthetic valve dysfunction and the best options (surgical, transcatheter or medical) for the management of patients with this kind of dysfunction, as well as to discover how valve design impacts on durability and what the future holds...
Transcatheter mitral valve interventions: clinical outcomes 2
28 Nov 2022 – From PCR London Valves 2022
This PCR LV 2022 session will enable you to discover outcomes of transcatheter edge-to-edge MVR in patients with right ventricle dysfunction, TEER for MR early after myocardial infarction, or a predictive selection of patients for TMVR, among others!
TAVI: technical considerations
28 Nov 2022 – From PCR London Valves 2022
Consult this session on TAVI technical considerations to discover a selection of cases presented during PCR LV 2022: transseptal snaring as a bailout from valvuloplasty balloon entrapment within a self-expanding valve, severe thrombocytopenia and severe aortic stenosis, embolisation of a fully deployed Evolute valve due to chest...
Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn how to perform a mitral transcatheter edge-to-edge repair procedure from start to finish, to learn more about currently available devices and which one to use in specific patients, and to understand how optimal procedural imaging and device steering determine the best...
Mitral edge-to-edge repair: surgical and transcatheter approaches - LIVE case
29 Nov 2022 – From PCR London Valves 2022
Learn from these 2 cases of primary mitral repair using percutaneous and surgical approaches:
- LIVE case - A 90-year-old male with history of LAD PCI 23 years ago and paroxysmal atrial fibrillation presents a primary mitral regurgitation (P2 prolapse) on mildly dilated LV and preserved LV function.
The operators...
Aortic stenosis and concomitant mitral valve disease
29 Nov 2022 – From PCR London Valves 2022
Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.
Aortic stenosis and concomitant coronary artery disease
29 Nov 2022 – From PCR London Valves 2022
Consult this session dedicated to aortic stenosis and concomitant coronary artery disease to learn how and when to screen for CAD in TAVI candidates, how to optimise your procedure to facilitate future coronary access, and to discover some tips and tricks for successful coronary angiography and PCI after TAVI.
All you need to know before starting a mitral valve-in-valve or valve-in-ring procedure
29 Nov 2022 – From PCR London Valves 2022
Discover all you need to know before starting a mitral valve-in-valve or valve-in-ring procedure in this session: learn how to evaluate patients with an indication for these procedures, how to identify the risks and determine the choice of prosthesis, the different steps of the procedure using a transseptal approach, and...
Mitral annular calcification - From diagnosis to treatment
29 Nov 2022 – From PCR London Valves 2022
Focus on mitral annular calcification: from diagnosis to treatment, learn more about the prevalence and clinical importance of MAC, understand the challenges of different therapeutic approaches and discover the current results and perspectives on transcatheter mitral valve implantation in patients with MAC.
Emerging indications for TAVI
17 May 2022 – From EuroPCR 2022
Streamlining transfemoral TAVI in patients with peripheral atherosclerosis
17 May 2022 – From EuroPCR 2022
TAVI durability: important considerations for patient lifetime management
18 May 2022 – From EuroPCR 2022
Managing acute coronary perforation: a simulation-based team approach
18 May 2022 – From EuroPCR 2022
IVUS and OCT: when, how, why?
18 May 2022 – From EuroPCR 2022
Streamlined TAVI with Tokyo Live @EuroPCR
19 May 2022 – From EuroPCR 2022
Watch the live case from Milan, Italy, of an 88-year-old female patient with hypertension who was admitted for dyspnoea with discovery of severe aortic stenosis to consider state-of-the-art TAVI.
EuroPCR 2022 Andreas Grüntzig Ethica Award
19 May 2022 – From EuroPCR 2022
This award is an opportunity to highlight and thank nurses and allied professionals from all around the world for their unwavering commitment and outstanding skills, and to honour those who have been especially recognised during the Covid-19 pandemic.
How should I treat ostial circumflex restenosis?
19 May 2022 – From EuroPCR 2022
Consider how to treat circumflex restenosis after a left main crossover stent and circumflex restenosis after left main PCI with 2 stents and try to learn from the two cases presented in this session: what are the ostial circumflex restenosis mechanisms, and the treatment options? What...
Secondary mitral regurgitation: when and how to treat
19 May 2022 – From EuroPCR 2022
Watch a 46-year-old patient from Toulouse presenting a congestive heart failure syndrome with a severe secondary mitral regurgitation being treated live!
Image-guided bifurcation stenting - In vitro beating heart simulation-based learning from Japan
18 May 2022 – From EuroPCR 2022
The focus of this EuroPCR 2022 session is on complex bifurcation intervention: learn a step-wise approach using imaging in a bifurcation stenting strategy, acknowledge the geographical differences in the way we approach these techniques, and experience the use of simulation-based learning on an in vitro beating...
The Future of TAVI
19 May 2022 – From EuroPCR 2022
Consut this session if you want to appraise the originality of the TAVI concept, to learn the feasibility of minimalist procedure and fast track patient pathway and to understand the expansion of indications and the future of TAVI.
